Literature DB >> 34182779

Accumulation of Succinyl Coenzyme A Perturbs the Methicillin-Resistant Staphylococcus aureus (MRSA) Succinylome and Is Associated with Increased Susceptibility to Beta-Lactam Antibiotics.

Christopher Campbell1, Claire Fingleton1, Merve S Zeden1, Emilio Bueno2, Laura A Gallagher1, Dhananjay Shinde3, Jongsam Ahn3, Heather M Olson4, Thomas L Fillmore4, Joshua N Adkins4, Fareha Razvi3, Kenneth W Bayles3, Paul D Fey3, Vinai C Thomas3, Felipe Cava2, Geremy C Clair4, James P O'Gara1.   

Abstract

Penicillin binding protein 2a (PBP2a)-dependent resistance to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) is regulated by the activity of the tricarboxylic acid (TCA) cycle via a poorly understood mechanism. We report that mutations in sucC and sucD, but not other TCA cycle enzymes, negatively impact β-lactam resistance without changing PBP2a expression. Increased intracellular levels of succinyl coenzyme A (succinyl-CoA) in the sucC mutant significantly perturbed lysine succinylation in the MRSA proteome. Suppressor mutations in sucA or sucB, responsible for succinyl-CoA biosynthesis, reversed sucC mutant phenotypes. The major autolysin (Atl) was the most succinylated protein in the proteome, and increased Atl succinylation in the sucC mutant was associated with loss of autolytic activity. Although PBP2a and PBP2 were also among the most succinylated proteins in the MRSA proteome, peptidoglycan architecture and cross-linking were unchanged in the sucC mutant. These data reveal that perturbation of the MRSA succinylome impacts two interconnected cell wall phenotypes, leading to repression of autolytic activity and increased susceptibility to β-lactam antibiotics. IMPORTANCE mecA-dependent methicillin resistance in MRSA is subject to regulation by numerous accessory factors involved in cell wall biosynthesis, nucleotide signaling, and central metabolism. Here, we report that mutations in the TCA cycle gene, sucC, increased susceptibility to β-lactam antibiotics and was accompanied by significant accumulation of succinyl-CoA, which in turn perturbed lysine succinylation in the proteome. Although cell wall structure and cross-linking were unchanged, significantly increased succinylation of the major autolysin Atl, which was the most succinylated protein in the proteome, was accompanied by near complete repression of autolytic activity. These findings link central metabolism and levels of succinyl-CoA to the regulation of β-lactam antibiotic resistance in MRSA through succinylome-mediated control of two interlinked cell wall phenotypes. Drug-mediated interference of the SucCD-controlled succinylome may help overcome β-lactam resistance.

Entities:  

Keywords:  MRSA; TCA cycle; antibiotic resistance; beta-lactams; succinyl-CoA; succinylome

Year:  2021        PMID: 34182779     DOI: 10.1128/mBio.00530-21

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  4 in total

Review 1.  An Interplay of Multiple Positive and Negative Factors Governs Methicillin Resistance in Staphylococcus aureus.

Authors:  Bohdan L Bilyk; Viralkumar V Panchal; Mariana Tinajero-Trejo; Jamie K Hobbs; Simon J Foster
Journal:  Microbiol Mol Biol Rev       Date:  2022-04-14       Impact factor: 13.044

2.  Acetylome and Succinylome Profiling of Edwardsiella tarda Reveals Key Roles of Both Lysine Acylations in Bacterial Antibiotic Resistance.

Authors:  Yuying Fu; Lishan Zhang; Huanhuan Song; Junyan Liao; Li Lin; Wenjia Jiang; Xiaoyun Wu; Guibin Wang
Journal:  Antibiotics (Basel)       Date:  2022-06-23

3.  Proteomic profiling of lysine acetylation and succinylation in Staphylococcus aureus.

Authors:  Jingyan Xia; Jinliang Liu; Feng Xu; Hui Zhou
Journal:  Clin Transl Med       Date:  2022-10

4.  Identification of Methicillin-Resistant Staphylococcus aureus (MRSA) Genetic Factors Involved in Human Endothelial Cells Damage, an Important Phenotype Correlated with Persistent Endovascular Infection.

Authors:  Xia Xiao; Yi Li; Liang Li; Yan Q. Xiong
Journal:  Antibiotics (Basel)       Date:  2022-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.